Join the club for FREE to access the whole archive and other member benefits.

David Liu

Richard Merkin Professor and Vice-Chair of the Faculty at Broad Institute of MIT and Harvard

David R. Liu is the Richard Merkin Professor, Director of the Merkin Institute of Transformative Technologies in Healthcare, and Vice-Chair of the Faculty at the Broad Institute of Harvard and MIT; Thomas Dudley Cabot Professor of the Natural Sciences and Professor of Chemistry and Chemical Biology at Harvard University; and Howard Hughes Medical Institute Investigator.
Liu has published >170 papers and is the inventor of >65 issued U.S. patents. In 2016 he was named one of the Top 20 Translational Researchers in the world by Nature Biotechnology, and in 2017 was named to the Nature’s 10 researchers in world and to the Foreign Policy Leading Global Thinkers.

Visit website: https://liugroup.us/

 davidrliu

 david-r-liu-465394185

 liugroup

See also: Academia Harvard University - Private Ivy League research university in Massachusetts

Details last updated 22-Oct-2019

David Liu Blog Posts

New cancer therapies in 2022 achieving unprecedented remissions - reviewing a year of hope
27-Jan-2023

New cancer therapies in 2022 achieving unprecedented remissions - reviewing a year of hope

Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology

David Liu News

Therapeutic applications of base editing clears girl's leukemia

BBC - 11-Dec-2022

Base editing can soon be a part in taking control of our genomes to fight genetic diseases

Read more...

Prime editing as a way of "editing" genes

BBC - 21-Oct-2019

There are around 75,000 mutations caused by DNA errors and prime editing can correct 89% of them

Read more...